- Home
- CCEL vs NXN Comparison
CCEL vs NXN Comparison
Compare CCEL & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- NXN
- Stock Information
- Founded
- CCEL 1989
- NXN 1992
- Country
- CCEL United States
- NXN United States
- Employees
- CCEL N/A
- NXN N/A
- Industry
- CCEL Managed Health Care
- NXN Trusts Except Educational Religious and Charitable
- Sector
- CCEL Health Care
- NXN Finance
- Exchange
- CCEL Nasdaq
- NXN Nasdaq
- Market Cap
- CCEL 51.9M
- NXN 46.2M
- IPO Year
- CCEL 1997
- NXN N/A
- Fundamental
- Price
- CCEL $5.56
- NXN $11.50
- Analyst Decision
- CCEL Strong Buy
- NXN
- Analyst Count
- CCEL 1
- NXN 0
- Target Price
- CCEL $8.50
- NXN N/A
- AVG Volume (30 Days)
- CCEL 12.2K
- NXN 9.7K
- Earning Date
- CCEL 04-15-2025
- NXN 01-01-0001
- Dividend Yield
- CCEL 4.45%
- NXN 4.23%
- EPS Growth
- CCEL N/A
- NXN N/A
- EPS
- CCEL 0.01
- NXN 0.24
- Revenue
- CCEL $32,102,750.00
- NXN N/A
- Revenue This Year
- CCEL $2.49
- NXN N/A
- Revenue Next Year
- CCEL $0.95
- NXN N/A
- P/E Ratio
- CCEL $346.31
- NXN $48.42
- Revenue Growth
- CCEL 2.33
- NXN N/A
- 52 Week Low
- CCEL $4.96
- NXN $10.64
- 52 Week High
- CCEL $9.50
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- CCEL 40.47
- NXN 53.52
- Support Level
- CCEL $5.38
- NXN $11.34
- Resistance Level
- CCEL $5.93
- NXN $11.47
- Average True Range (ATR)
- CCEL 0.40
- NXN 0.12
- MACD
- CCEL 0.04
- NXN 0.03
- Stochastic Oscillator
- CCEL 50.00
- NXN 91.81
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.